Skip to main content

letter

. 2013 Apr 3;34(1):57–58. [Article in Spanish] doi: 10.1016/S0212-6567(04)79454-8

Oliguria y elevación de la creatinfosfocinasa secundaria a citalopram

P Vich Pérez ^a, C Ruiz Arribas ^b, R Collados Navas ^c, R Pastor-Sánchez ^d

PMCID: PMC7688698 PMID: 15207203

The content is available as a PDF (85.3 KB).

Bibliografía

1.Jonasson B., Saldeen T. Citalopram in fatal poisoning cases. Forensic Sci Int. 2002;126:1–6. doi: 10.1016/s0379-0738(01)00632-6. [DOI] [PubMed] [Google Scholar]
2.Zullino D., Brauchli S., Horvath A., Baumann P. Inapropiate antidiuretic hormone secretion and rhabdomyolysis associated with citalopram. Therapie. 2000;55:651–652. [PubMed] [Google Scholar]
3.Citalopram. AntidepressantsFacts 2003 [consultado 1/08/72003]. Disponible http://www.antidepressantsfacts.com/celexa.htm
4.Aydin N, Anaç E, Çaykôylü A, Akçay F. Neuroleptic malignant syndrome due to citalopram overdose [carta]. Can J PsyÂchiatry 2000;45:941-2. Disponible http://www.cpa-apc.org/Publications/Archives/CJP/2000/Dec/Letters6.asp [PubMed]
5.Other events observed during the postÂmarketing evaluation of celexa (citalopram HBr). The FDA Safety Information and Adverse Event Reporting Program. 2002 Nov [consultado el 01/08/2003]: DispoÂnible http://www.fda.gov/medwatch/SA-FETY/2002/nov02.htm

ACTIONS

RESOURCES